19
Participants
Start Date
February 20, 2018
Primary Completion Date
June 12, 2019
Study Completion Date
June 12, 2019
GLWL-01
Oral administration of 3 capsules, twice a day
Placebo
Oral administration of 3 capsules, twice a day
University of Florida, Gainesville
Vanderbilt University, Nashville
University Hospitals, Cleveland Medical Center, Cleveland
Rady Children's Hospital San Diego, San Diego
Alberta Diabetes Institute, University of Alberta, Edmonton
CRCHUM, Montreal
Centre Hospitalier Universitaire Ste-Justine, Montreal
Lead Sponsor
GLWL Research Inc.
OTHER